TRNS 📈 Transcat - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8935291075
TRNS: Calibration, Laboratory, Instruments, Services, Test, Measurement
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York. Web URL: https://www.transcat.com
Additional Sources for TRNS Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
TRNS Stock Overview
Market Cap in USD | 1,015m |
Sector | Industrials |
Industry | Industrial Distribution |
GiC Sub-Industry | Trading Companies & Distributors |
IPO / Inception | 1990-03-27 |
TRNS Stock Ratings
Growth 5y | 82.1% |
Fundamental | 35.7% |
Dividend | - |
Rel. Strength Industry | -86.5 |
Analysts | 4.4/5 |
Fair Price Momentum | 107.11 USD |
Fair Price DCF | 47.13 USD |
TRNS Dividends
No Dividends PaidTRNS Growth Ratios
Growth Correlation 3m | -61.2% |
Growth Correlation 12m | 26.5% |
Growth Correlation 5y | 93.8% |
CAGR 5y | 26.63% |
CAGR/Mean DD 5y | 2.00 |
Sharpe Ratio 12m | 0.07 |
Alpha | -20.98 |
Beta | 0.68 |
Volatility | 48.34% |
Current Volume | 96.5k |
Average Volume 20d | 57.5k |
What is the price of TRNS stocks?
As of December 22, 2024, the stock is trading at USD 105.75 with a total of 96,540 shares traded.
Over the past week, the price has changed by -3.99%, over one month by +2.41%, over three months by -19.57% and over the past year by +2.42%.
As of December 22, 2024, the stock is trading at USD 105.75 with a total of 96,540 shares traded.
Over the past week, the price has changed by -3.99%, over one month by +2.41%, over three months by -19.57% and over the past year by +2.42%.
Is Transcat a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Transcat (NASDAQ:TRNS) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 35.70 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRNS as of December 2024 is 107.11. This means that TRNS is currently overvalued and has a potential downside of 1.29%.
Partly, yes. Based on ValueRay Fundamental Analyses, Transcat (NASDAQ:TRNS) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 35.70 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRNS as of December 2024 is 107.11. This means that TRNS is currently overvalued and has a potential downside of 1.29%.
Is TRNS a buy, sell or hold?
Transcat has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy TRNS.
Transcat has received a consensus analysts rating of 4.40. Therefor, it is recommend to buy TRNS.
- Strong Buy: 3
- Buy: 1
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecast for TRNS stock price target?
According to ValueRays Forecast Model, TRNS Transcat will be worth about 117.9 in December 2025. The stock is currently trading at 105.75. This means that the stock has a potential upside of +11.5%.
According to ValueRays Forecast Model, TRNS Transcat will be worth about 117.9 in December 2025. The stock is currently trading at 105.75. This means that the stock has a potential upside of +11.5%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 121.2 | 14.6% |
Analysts Target Price | 106.2 | 0.4% |
ValueRay Target Price | 117.9 | 11.5% |